Mircera injection syringe 12.5μg by Chugai Pharmaceutical contains epoetin beta pegol (genetical recombination), a long-acting erythropoiesis stimulating agent. Approved in Japan in 2018, it treats renal anemia and has YJ code 3999432G8024, supplied as 12.5μg in 0.3mL per tube.
Mircera injection syringe 12.5μg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →